Costa Saroukos

AcquisitionPrivateMajority

target

XIIDRA

bidder

Novartis

£4,066m

52 dealmakers

Ukraine

AcquisitionMajorityPrivateCross BorderPrivate Equity

target

Takeda Pharmaceutical Company (drug Portfolio)

bidder

Acino International

£159m

24 dealmakers

Russian Federation

MajorityAcquisitionPrivateCross Border

target

Takeda Pharmaceutical Company (otc Portfolio)

bidder

Stada Arzneimittel

£512m

37 dealmakers

AcquisitionPrivateMajorityCross Border

target

Pvp Biologics

bidder

Takeda Pharmaceutical Company

£255m

12 dealmakers

DenmarkPoland

AcquisitionPrivateMajorityCross BorderDisposal

target

Takeda Pharmaceutical Company (otc Assets)

bidder

Orifarm Group

£530m

41 dealmakers

ArgentinaJapan

MajorityDomesticAcquisitionPrivate

target

Takeda Pharmaceutical Company (selected Otc Assets)

bidder

Hypera

£601m

3 dealmakers

PrivateAcquisitionMajorityPrivate EquityCross Border

Health Care Services

target

Takeda Consumer Healthcare Company

bidder

Blackstone Group

£1,756m

38 dealmakers

MajorityPrivateCross BorderAcquisitionPrivate Equity

Medical Equipment

target

Takeda (tachosil)

bidder

Gtcr

£320m

78 dealmakers

Venture CapitalAcquisitionDomesticPrivateMajorityPrivate Equity

Biotechnology

target

Velosbio

bidder

Merck & Co

£2,116m

55 dealmakers

PrivateMajorityCross BorderAcquisition

Medical Supplies

target

Takeda Pharmaceutical Company (prescription Products)

bidder

Cheplapharm Arzneimittel Gbmh

£412m

7 dealmakers

PrivateMajorityAcquisitionCross Border

target

Maverick Therapeutics

bidder

Takeda Pharmaceutical Company

£379m

12 dealmakers

AcquisitionCross BorderMajorityPrivate

target

Takeda Pharmaceutical (non-core Assets)

bidder

HASTEN

£230m

13 dealmakers